Mina Sooch

Mina is a co-founder and CEO of of Ocuphire Pharma. With more than 23 years of pharmaceutical and biotech experience as entrepreneur, venture capitalist and strategist, Ms. Sooch has successfully raised hundreds of millions of dollars for more than 10 biotechnology, pharmaceutical and medical device companies, which included two successful IPOs. Prior to Ocuphire, Ms. Sooch was a co-founder and CEO of Gemphire Therapeutics, a publicly traded, clinical-stage cardiovascular company. Ms. Sooch was a co-founder and CEO of ProNAi Therapeutics, a public, clinical-stage oncology company. Ms. Sooch received an M.B.A. from Harvard Business School and a B.S. summa cum laude in Chemical Engineering from Wayne State University in Michigan.